Non-transplant eligible multiple myeloma: deciphering optimal first line regimens

Iuliana Vaxman; Morie Gertz

doi:10.1080/10428194.2020.1716223

Non-transplant eligible multiple myeloma: deciphering optimal first line regimens

Hematology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	504-506
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	61
Issue number	3
DOIs	https://doi.org/10.1080/10428194.2020.1716223
State	Published - Feb 23 2020

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1080/10428194.2020.1716223

Cite this

@article{8e14645351874f12bcb4de8644617d50,

title = "Non-transplant eligible multiple myeloma: deciphering optimal first line regimens",

author = "Iuliana Vaxman and Morie Gertz",

year = "2020",

month = feb,

day = "23",

doi = "10.1080/10428194.2020.1716223",

language = "English (US)",

volume = "61",

pages = "504--506",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "3",

}

TY - JOUR

T1 - Non-transplant eligible multiple myeloma

T2 - deciphering optimal first line regimens

AU - Vaxman, Iuliana

AU - Gertz, Morie

PY - 2020/2/23

Y1 - 2020/2/23

UR - http://www.scopus.com/inward/record.url?scp=85078454779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078454779&partnerID=8YFLogxK

U2 - 10.1080/10428194.2020.1716223

DO - 10.1080/10428194.2020.1716223

M3 - Comment/debate

C2 - 31975634

AN - SCOPUS:85078454779

SN - 1042-8194

VL - 61

SP - 504

EP - 506

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 3

ER -

Non-transplant eligible multiple myeloma: deciphering optimal first line regimens

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this